<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37108335</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7169</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24087169</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons in the spinal cord, brain stem, and cerebral cortex. Biomarkers for ALS are essential for disease detection and to provide information on potential therapeutic targets. Aminopeptidases catalyze the cleavage of amino acids from the amino terminus of protein or substrates such as neuropeptides. Since certain aminopeptidases are known to increase the risk of neurodegeneration, such mechanisms may reveal new targets to determine their association with ALS risk and their interest as a diagnostic biomarker. The authors performed a systematic review and meta-analyses of genome-wide association studies (GWASs) to identify reported aminopeptidases genetic loci associated with the risk of ALS. PubMed, Scopus, CINAHL, ISI Web of Science, ProQuest, LILACS, and Cochrane databases were searched to retrieve eligible studies in English or Spanish, published up to 27 January 2023. A total of 16 studies were included in this systematic review, where a series of aminopeptidases could be related to ALS and could be promising biomarkers (DPP1, DPP2, DPP4, LeuAP, pGluAP, and PSA/NPEPPS). The literature reported the association of single-nucleotide polymorphisms (SNPs: rs10260404 and rs17174381) with the risk of ALS. The genetic variation rs10260404 in the DPP6 gene was identified to be highly associated with ALS susceptibility, but meta-analyses of genotypes in five studies in a matched cohort of different ancestry (1873 cases and 1861 control subjects) showed no ALS risk association. Meta-analyses of eight studies for minor allele frequency (MAF) also found no ALS association for the "C" allele. The systematic review identified aminopeptidases as possible biomarkers. However, the meta-analyses for rs1060404 of DPP6 do not show a risk associated with ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Teruel-Pe&#xf1;a</LastName><ForeName>B&#xe1;rbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Ja&#xe9;n, 23071 Ja&#xe9;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Health Sciences, Ceuta University of Granada, 51001 Ceuta, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Urquiza</LastName><ForeName>Jos&#xe9; Lu&#xed;s</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-8684-1817</Identifier><AffiliationInfo><Affiliation>Nursing Department, Faculty of Health Sciences, Ceuta University of Granada, 51001 Ceuta, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suleiman-Martos</LastName><ForeName>Nora</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4133-0092</Identifier><AffiliationInfo><Affiliation>Nursing Department, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0624-9504</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, University of Ja&#xe9;n, 23071 Ja&#xe9;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-C&#xf3;zar</LastName><ForeName>Francisco Jos&#xe9;</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0003-3720-259X</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Biotechnology and Public Health, University of Cadiz, 11003 Cadiz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-S&#xe1;nchez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Ja&#xe9;n, 23071 Ja&#xe9;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Martos</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6387-4456</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of San Pablo CEU, 28003 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez-V&#xed;as</LastName><ForeName>Germ&#xe1;n</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9546-9148</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Health Sciences, Ceuta University of Granada, 51001 Ceuta, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PPJIA2022.09</GrantID><Agency>University of Granada</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.11.-</RegistryNumber><NameOfSubstance UI="D000626">Aminopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000626" MajorTopicYN="N">Aminopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aminopeptidase</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37108335</ArticleId><ArticleId IdType="pmc">PMC10138961</ArticleId><ArticleId IdType="doi">10.3390/ijms24087169</ArticleId><ArticleId IdType="pii">ijms24087169</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Meininger V. Dose-Ranging Study of Riluzole in Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347:1425&#x2013;1431. doi: 10.1016/S0140-6736(96)91680-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91680-3</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;bler A., Winter S., Ludolph A.C., Hautzinger M., Birbaumer N. Severity of Depressive Symptoms and Quality of Life in Patients with Amyotrophic Lateral Sclerosis. Neurorehabilit. Neural Repair. 2005;19:182&#x2013;193. doi: 10.1177/1545968305276583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968305276583</ArticleId><ArticleId IdType="pubmed">16093409</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf3; A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Incidence of Amyotrophic Lateral Sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N., Atsuta N., Yokoi D., Nakamura R., Nakatochi M., Katsuno M., Izumi Y., Kanai K., Hattori N., Taniguchi A., et al. Prognosis of Amyotrophic Lateral Sclerosis Patients Undergoing Tracheostomy Invasive Ventilation Therapy in Japan. J. Neurol. Neurosurg. Psychiatry. 2020;91:285&#x2013;290. doi: 10.1136/jnnp-2019-322213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322213</ArticleId><ArticleId IdType="pubmed">31937581</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D., Zickler C., H&#xe4;cker S., Bruno M.A., Demertzi A., Pellas F., Laureys S., K&#xfc;bler A. Life Can Be Worth Living in Locked-in Syndrome. Prog. Brain Res. 2009;177:339&#x2013;351. doi: 10.1016/S0079-6123(09)17723-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6123(09)17723-3</ArticleId><ArticleId IdType="pubmed">19818912</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Baas F., Iyer A., ten Asbroek A.L.M.A., Morello G., Cavallaro S. Molecular Classification of Amyotrophic Lateral Sclerosis by Unsupervised Clustering of Gene Expression in Motor Cortex. Neurobiol. Dis. 2015;74:359&#x2013;376. doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers J.E., Melki J., Meininger V., Glass J.D., van den Berg L.H., van Es M.A., Sapp P.C., van Vught P.W.J., McKenna-Yasek D.M., Blauw H.M., et al. Reduced Expression of the Kinesin-Associated Protein 3 (KIFAP3) Gene Increases Survival in Sporadic Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2009;106:9004&#x2013;9009. doi: 10.1073/pnas.0812937106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812937106</ArticleId><ArticleId IdType="pmc">PMC2683883</ArticleId><ArticleId IdType="pubmed">19451621</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymick J.C., Talbot K., Traynor B.J. Genetics of Sporadic Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 2007;16:R233&#x2013;R242. doi: 10.1093/hmg/ddm215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm215</ArticleId><ArticleId IdType="pubmed">17911166</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical Genetics of Amyotrophic Lateral Sclerosis: What Do We Really Know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Shaw P.J., de Vos K.J. Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities? Front. Mol. Neurosci. 2017;10:123. doi: 10.3389/fnmol.2017.00123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00123</ArticleId><ArticleId IdType="pmc">PMC5411428</ArticleId><ArticleId IdType="pubmed">28512398</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisholm C., Lum J., Farrawell N., Yerbury J. Ubiquitin Homeostasis Disruption, a Common Cause of Proteostasis Collapse in Amyotrophic Lateral Sclerosis? Neural Regen. Res. 2022;17:2218. doi: 10.4103/1673-5374.335786.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.335786</ArticleId><ArticleId IdType="pmc">PMC9083156</ArticleId><ArticleId IdType="pubmed">35259837</ArticleId></ArticleIdList></Reference><Reference><Citation>Checler F., Valverde A. Aminopeptidase A and Dipeptidyl Peptidase 4: A Pathogenic Duo in Alzheimer&#x2019;s Disease? Neural Regen. Res. 2022;17:2215&#x2013;2217. doi: 10.4103/1673-5374.335818.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.335818</ArticleId><ArticleId IdType="pmc">PMC9083140</ArticleId><ArticleId IdType="pubmed">35259836</ArticleId></ArticleIdList></Reference><Reference><Citation>Albiston A.L., Fernando R., Ye S., Peck G.R., Chai S.Y. Alzheimer&#x2019;s, Angiotensin IV and an Aminopeptidase. Biol. Pharm. Bull. 2004;27:765&#x2013;767. doi: 10.1248/bpb.27.765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.27.765</ArticleId><ArticleId IdType="pubmed">15187413</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D., Perry E.K. Comparison of Aminopeptidase, Dipeptidyl Aminopeptidase and Tripeptidyl Aminopeptidase Activities in Brain Tissue from Normal and Alzheimer&#x2019;s Disease Cases. J. Neurol. Sci. 1990;98:13&#x2013;20. doi: 10.1016/0022-510X(90)90178-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(90)90178-P</ArticleId><ArticleId IdType="pubmed">2230828</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;hnert P., Schmidt W., Emmerlich P., Goihl A., Wrenger S., Bank U., Nordhoff K., T&#xe4;ger M., Ansorge S., Reinhold D., et al. Dipeptidyl Peptidase IV, Aminopeptidase N and DPIV/APN-like Proteases in Cerebral Ischemia. J. Neuroinflamm. 2012;9:44. doi: 10.1186/1742-2094-9-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-44</ArticleId><ArticleId IdType="pmc">PMC3359160</ArticleId><ArticleId IdType="pubmed">22373413</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Badri G., Leggio G.M., Musumeci G., Marzagalli R., Drago F., Castorina A. Tackling Dipeptidyl Peptidase IV in Neurological Disorders. Neural Regen. Res. 2018;13:26&#x2013;34. doi: 10.4103/1673-5374.224365.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.224365</ArticleId><ArticleId IdType="pmc">PMC5840985</ArticleId><ArticleId IdType="pubmed">29451201</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhou M., Sun J., Guo A., Fernando R.L., Chen Y., Peng P., Zhao G., Deng Y. DPP-4 Inhibitor Improves Learning and Memory Deficits and AD-like Neurodegeneration by Modulating the GLP-1 Signaling. Neuropharmacology. 2019;157:107668. doi: 10.1016/j.neuropharm.2019.107668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2019.107668</ArticleId><ArticleId IdType="pubmed">31199957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda Y., Nagase N., Tsuji A., Kitagishi Y., Matsuda S. Neuroprotection by Dipeptidyl-Peptidase-4 Inhibitors and Glucagon-like Peptide-1 Analogs via the Modulation of AKT-Signaling Pathway in Alzheimer&#x2019;s Disease. World J. Biol. Chem. 2021;12:104&#x2013;113. doi: 10.4331/wjbc.v12.i6.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.4331/wjbc.v12.i6.104</ArticleId><ArticleId IdType="pmc">PMC8637616</ArticleId><ArticleId IdType="pubmed">34904048</ArticleId></ArticleIdList></Reference><Reference><Citation>Takala T.E.S., Myllyl&#xe4; V.V., Salminen A., Tolonen U., Hassinen I.E., Vihko V. Lysosomal and Nonlysosomal Hydrolases of Skeletal Muscle in Neuromuscular Diseases. Arch. Neurol. 1983;40:541&#x2013;544. doi: 10.1001/archneur.1983.04050080041006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1983.04050080041006</ArticleId><ArticleId IdType="pubmed">6351816</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., van Vught P.W.J., Blauw H.M., Franke L., Saris C.G.J., van den Bosch L., de Jong S.W., de Jong V., Baas F., van&#x2019;t Slot R., et al. Genetic Variation in DPP6 Is Associated with Susceptibility to Amyotrophic Lateral Sclerosis. Nat. Genet. 2008;40:29&#x2013;31. doi: 10.1038/ng.2007.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2007.52</ArticleId><ArticleId IdType="pubmed">18084291</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., et al. Structural Variation of Chromosomes in Autism Spectrum Disorder. Am. J. Hum. Genet. 2008;82:477&#x2013;488. doi: 10.1016/j.ajhg.2007.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2007.12.009</ArticleId><ArticleId IdType="pmc">PMC2426913</ArticleId><ArticleId IdType="pubmed">18252227</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Morales V., Rodr&#xed;guez-Bey G., G&#xf3;mez-P&#xe9;rez L., Dom&#xed;nguez-V&#xed;as G., Gonz&#xe1;lez-Forero D., Portillo F., Campos-Caro A., Gento-Caro &#xc1;., Issaoui N., Soler R.M., et al. Sp1-Regulated Expression of P11 Contributes to Motor Neuron Degeneration by Membrane Insertion of TASK1. Nat. Commun. 2019;10:3784. doi: 10.1038/s41467-019-11637-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11637-4</ArticleId><ArticleId IdType="pmc">PMC6706379</ArticleId><ArticleId IdType="pubmed">31439839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadal M.S., Ozaita A., Amarillo Y., Vega-Saenz De Miera E., Ma Y., Mo W., Goldberg E.M., Misumi Y., Ikehara Y., Neubert T.A., et al. The CD26-Related Dipeptidyl Aminopeptidase-like Protein DPPX Is a Critical Component of Neuronal A-Type K+ Channels. Neuron. 2003;37:449&#x2013;461. doi: 10.1016/S0896-6273(02)01185-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)01185-6</ArticleId><ArticleId IdType="pubmed">12575952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W., Newell E.W., Jugloff D.G.M., Jones O.T., Schlichter L.C. Cell Surface Targeting and Clustering Interactions between Heterologously Expressed PSD-95 and the Shal Voltage-Gated Potassium Channel, Kv4.2. J. Biol. Chem. 2002;277:20423&#x2013;20430. doi: 10.1074/jbc.M109412200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109412200</ArticleId><ArticleId IdType="pubmed">11923279</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W., Maffie J.K., Lin L., Petralia R.S., Rudy B., Hoffman D.A. DPP6 Establishes the A-Type K(+) Current Gradient Critical for the Regulation of Dendritic Excitability in CA1 Hippocampal Neurons. Neuron. 2011;71:1102&#x2013;1115. doi: 10.1016/j.neuron.2011.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.08.008</ArticleId><ArticleId IdType="pmc">PMC3184237</ArticleId><ArticleId IdType="pubmed">21943606</ArticleId></ArticleIdList></Reference><Reference><Citation>Malloy C., Ahern M., Lin L., Hoffman D.A. Neuronal Roles of the Multifunctional Protein Dipeptidyl Peptidase-like 6 (DPP6) Int. J. Mol. Sci. 2022;23:9184. doi: 10.3390/ijms23169184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169184</ArticleId><ArticleId IdType="pmc">PMC9409431</ArticleId><ArticleId IdType="pubmed">36012450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Petralia R.S., Holtzclaw L., Wang Y.X., Abebe D., Hoffman D.A. Alzheimer&#x2019;s Disease/Dementia-Associated Brain Pathology in Aging DPP6-KO Mice. Neurobiol. Dis. 2022;174:105887. doi: 10.1016/j.nbd.2022.105887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105887</ArticleId><ArticleId IdType="pmc">PMC9617781</ArticleId><ArticleId IdType="pubmed">36209950</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S., Berger S., Ding J., Schymick J.C., Washecka N., Hernandez D.G., Greenway M.J., Bradley D.G., Traynor B.J., Hardiman O. A Genome-Wide Association Study of Sporadic ALS in a Homogenous Irish Population. Hum. Mol. Genet. 2008;17:768&#x2013;774. doi: 10.1093/hmg/ddm361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm361</ArticleId><ArticleId IdType="pubmed">18057069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S., Tomik B., Bradley D.G., Slowik A., Hardiman O. Screening for Replication of Genome-Wide SNP Associations in Sporadic ALS. Eur. J. Hum. Genet. 2009;17:213&#x2013;218. doi: 10.1038/ejhg.2008.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2008.194</ArticleId><ArticleId IdType="pmc">PMC2986065</ArticleId><ArticleId IdType="pubmed">18987618</ArticleId></ArticleIdList></Reference><Reference><Citation>Witzel S., Mayer K., Oeckl P. Biomarkers for Amyotrophic Lateral Sclerosis. Curr. Opin. Neurol. 2022;35:699&#x2013;704. doi: 10.1097/WCO.0000000000001094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001094</ArticleId><ArticleId IdType="pubmed">35942674</ArticleId></ArticleIdList></Reference><Reference><Citation>Swindell W.R., Kruse C.P.S., List E.O., Berryman D.E., Kopchick J.J. ALS Blood Expression Profiling Identifies New Biomarkers, Patient Subgroups, and Evidence for Neutrophilia and Hypoxia. J. Transl. Med. 2019;17:170. doi: 10.1186/s12967-019-1909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1909-0</ArticleId><ArticleId IdType="pmc">PMC6530130</ArticleId><ArticleId IdType="pubmed">31118040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturmey E., Malaspina A. Blood Biomarkers in ALS: Challenges, Applications and Novel Frontiers. Acta Neurol. Scand. 2022;146:375&#x2013;388. doi: 10.1111/ane.13698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13698</ArticleId><ArticleId IdType="pmc">PMC9828487</ArticleId><ArticleId IdType="pubmed">36156207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vejux A., Namsi A., Nury T., Moreau T., Lizard G. Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols. Front. Mol. Neurosci. 2018;11:12. doi: 10.3389/fnmol.2018.00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00012</ArticleId><ArticleId IdType="pmc">PMC5797798</ArticleId><ArticleId IdType="pubmed">29445325</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N., Shaw P.J. Biomarkers in Amyotrophic Lateral Sclerosis: A Review of New Developments. Curr. Opin. Neurol. 2020;33:662&#x2013;668. doi: 10.1097/WCO.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000854</ArticleId><ArticleId IdType="pubmed">32796280</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A., Altman D.G., Tetzlaff J., Mulrow C., G&#xf8;tzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Healthcare Interventions: Explanation and Elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren G., Ma Z., Hui M., Kudo L.C., Hui K.-S., Karsten S.L. Cu, Zn-Superoxide Dismutase 1 (SOD1) Is a Novel Target of Puromycin-Sensitive Aminopeptidase (PSA/NPEPPS): PSA/NPEPPS Is a Possible Modifier of Amyotrophic Lateral Sclerosis. Mol. Neurodegener. 2011;6:29. doi: 10.1186/1750-1326-6-29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-29</ArticleId><ArticleId IdType="pmc">PMC3113298</ArticleId><ArticleId IdType="pubmed">21548977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Zeng Y., Huang R., Yang Y., Chen K., Song W., Zhao B., Li J., Yuan L., Shang H.-F. No Association of Five Candidate Genetic Variants with Amyotrophic Lateral Sclerosis in a Chinese Population. Neurobiol. Aging. 2012;33:2721.e3. doi: 10.1016/j.neurobiolaging.2012.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.004</ArticleId><ArticleId IdType="pubmed">22795786</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.J., Ince P.G., Falkous G., Mantle D. Cytoplasmic, Lysosomal and Matrix Protease Activities in Spinal Cord Tissue from Amyotrophic Lateral Sclerosis (ALS) and Control Patients. J. Neurol. Sci. 1996;139:71&#x2013;75. doi: 10.1016/0022-510X(96)00103-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00103-7</ArticleId><ArticleId IdType="pubmed">8899662</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan M., Seeley K.W., Jinwal U.K. Identification of Apo B48 and Other Novel Biomarkers in Amyotrophic Lateral Sclerosis Patient Fibroblasts. Biomark. Med. 2016;10:453&#x2013;462. doi: 10.2217/bmm-2016-0025.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2016-0025</ArticleId><ArticleId IdType="pubmed">27141953</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Bo R., Ghezzi S., Corti S., Santoro D., Prelle A., Mancuso M., Siciliano G., Briani C., Murri L., Bresolin N., et al. DPP6 Gene Variability Confers Increased Risk of Developing Sporadic Amyotrophic Lateral Sclerosis in Italian Patients. J. Neurol. Neurosurg. Psychiatry. 2008;79:1085. doi: 10.1136/jnnp.2008.149146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.149146</ArticleId><ArticleId IdType="pubmed">18708572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwee L.C., Liu Y., Haynes C., Gibson J.R., Stone A., Schichman S.A., Kamel F., Nelson L.M., Topol B., van den Eeden S.K., et al. A High-Density Genome-Wide Association Screen of Sporadic Als in US Veterans. PLoS ONE. 2012;7:e32768. doi: 10.1371/journal.pone.0032768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032768</ArticleId><ArticleId IdType="pmc">PMC3314660</ArticleId><ArticleId IdType="pubmed">22470424</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H., Valdmanis P.N., Dion P.A., Rouleau G.A. Analysis of DPP6 and FGGY as Candidate Genes for Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. 2010;11:389&#x2013;391. doi: 10.3109/17482960903358857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903358857</ArticleId><ArticleId IdType="pubmed">20001489</ArticleId></ArticleIdList></Reference><Reference><Citation>Khokhlov A.P., YuN S., Chekhonin V.P., Zotova E.E., Shmidt T.E., Zhuchenko T.D., Morozov S.G. Results of Clinical and Enzymatic Immunoassay Study of a Neurospecific Leucine Aminopeptidase in Neurological Patients. Neurosci. Behav. Physiol. 1992;22:65&#x2013;70. doi: 10.1007/BF01186671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01186671</ArticleId><ArticleId IdType="pubmed">1614622</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauw H.M., Al-Chalabi A., Andersen P.M., van Vught P.W.J., Diekstra F.P., van Es M.A., Saris C.G.J., Groen E.J.N., van Rheenen W., Koppers M., et al. A Large Genome Scan for Rare CNVs in Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 2010;19:4091&#x2013;4099. doi: 10.1093/hmg/ddq323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq323</ArticleId><ArticleId IdType="pubmed">20685689</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I., D&#x2019;Alfonso S., Gellera C., Ratti A., Cereda C., Penco S., Corrado L., Sorar&#xf9; G., Castellotti B., Tiloca C., et al. No Association of DPP6 with Amyotrophic Lateral Sclerosis in an Italian Population. Neurobiol. Aging. 2011;32:966&#x2013;967. doi: 10.1016/j.neurobiolaging.2009.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.05.014</ArticleId><ArticleId IdType="pubmed">19525032</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.-G., Zhang J.-H., Xie M.-Q., Liu M.-S., Li B.-H., Zhao Y.-H., Ren H.-T., Cui L.-Y. Association between DPP6 Polymorphism and the Risk of Sporadic Amyotrophic Lateral Sclerosis in Chinese Patients. Chin. Med. J. 2009;122:2989&#x2013;2992. doi: 10.3760/cma.j.issn.0366-6999.2009.24.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0366-6999.2009.24.014</ArticleId><ArticleId IdType="pubmed">20137488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Qiu W., Hu F., Zhang X., Deng Y., Nie H., Xu R. The Rs2619566, Rs10260404, and Rs79609816 Polymorphisms Are Associated With Sporadic Amyotrophic Lateral Sclerosis in Individuals of Han Ancestry From Mainland China. Front. Genet. 2021;12:679204. doi: 10.3389/fgene.2021.679204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.679204</ArticleId><ArticleId IdType="pmc">PMC8378233</ArticleId><ArticleId IdType="pubmed">34421992</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran R., Barrero F.J., Morales B., Luna J.D., Ramirez M., Vives F. Oxidative Stress and Aminopeptidases in Parkinson&#x2019;s Disease Patients with and without Treatment. Neurodegener. Dis. 2011;8:109&#x2013;116. doi: 10.1159/000315404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000315404</ArticleId><ArticleId IdType="pubmed">20714110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gard P.R., Fidalgo S., Lotter I., Richardson C., Farina N., Rusted J., Tabet N. Changes of Renin-Angiotensin System-Related Aminopeptidases in Early Stage Alzheimer&#x2019;s Disease. Exp. Gerontol. 2017;89:1&#x2013;7. doi: 10.1016/j.exger.2017.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2017.01.006</ArticleId><ArticleId IdType="pubmed">28069385</ArticleId></ArticleIdList></Reference><Reference><Citation>Khokhlov A.P., Savchenko I.N., Chekhonin V.P., Zotova E.E., Shmidt T.E., Zhuchenko T.D., Morozov S.G. Results of Clinical and Immunoenzymatic Studies of Neurospecific Leucine Aminopeptidase in Patients with Neurologic Disorders. Zhurnal Nevropatol. Psikhiatrii Im. SS Korsakova. 1990;90:20&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">1965362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui M., Hui K.S. A New Type of Neuron-Specific Aminopeptidase NAP-2 in Rat Brain Synaptosomes. Neurochem. Int. 2008;53:317&#x2013;324. doi: 10.1016/j.neuint.2008.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2008.09.003</ArticleId><ArticleId IdType="pmc">PMC2748861</ArticleId><ArticleId IdType="pubmed">18831998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudo L.C., Parfenova L., Ren G., Vi N., Hui M., Ma Z., Lau K., Gray M., Bardag-Gorce F., Wiedau-Pazos M., et al. Puromycin-Sensitive Aminopeptidase (PSA/NPEPPS) Impedes Development of Neuropathology in HPSA/TAU(P301L) Double-Transgenic Mice. Hum. Mol. Genet. 2011;20:1820&#x2013;1833. doi: 10.1093/hmg/ddr065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr065</ArticleId><ArticleId IdType="pubmed">21320871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh L.B., McKelvy J.F. An Aminopeptidase from Bovine Brain Which Catalyzes the Hydrolysis of Enkephalin. J. Neurochem. 1981;36:171&#x2013;178. doi: 10.1111/j.1471-4159.1981.tb02392.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1981.tb02392.x</ArticleId><ArticleId IdType="pubmed">6780659</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhutani N., Venkatraman P., Goldberg A.L. Puromycin-Sensitive Aminopeptidase Is the Major Peptidase Responsible for Digesting Polyglutamine Sequences Released by Proteasomes during Protein Degradation. EMBO J. 2007;26:1385&#x2013;1396. doi: 10.1038/sj.emboj.7601592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601592</ArticleId><ArticleId IdType="pmc">PMC1817637</ArticleId><ArticleId IdType="pubmed">17318184</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsten S.L., Parfenova L., Lau K., Pomakian J., Vinters H.V., Kudo L.C. Is Puromycin Sensitive Aminopeptidase (PSA) a Modifier of Amyotrophic Lateral Sclerosis That Acts on SOD1? Soc. Neurosci. Abstr. Viewer Itiner. Plan. 2009;39</Citation></Reference><Reference><Citation>Minnasch P., Yamamoto Y., Ohkubo I., Nishi K. Demonstration of Puromycin-Sensitive Alanyl Aminopeptidase in Alzheimer Disease Brain. Leg. Med. 2003;5:S285&#x2013;S287. doi: 10.1016/S1344-6223(02)00151-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1344-6223(02)00151-7</ArticleId><ArticleId IdType="pubmed">12935612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard F.J., Tomas F.M., Stern L.M. Increased Turnover of Muscle Contractile Proteins in Duchenne Muscular Dystrophy as Assessed by 3-Methylhistidine and Creatinine Excretion. Clin. Sci. 1979;56:347&#x2013;352. doi: 10.1042/cs0560347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0560347</ArticleId><ArticleId IdType="pubmed">477220</ArticleId></ArticleIdList></Reference><Reference><Citation>Myllyl&#xe4; R., Myllyl&#xe4; V.V., Tolonen U., Kivirikko K.I. Changes in Collagen Metabolism in Diseased Muscle. I. Biochemical Studies. Arch. Neurol. 1982;39:752&#x2013;755. doi: 10.1001/archneur.1982.00510240014004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1982.00510240014004</ArticleId><ArticleId IdType="pubmed">6291494</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson C.M., Kar N.C. Muscle Breakdown and Lysosomal Activation (Biochemistry) Ann. N. Y. Acad. Sci. 1979;317:465&#x2013;477. doi: 10.1111/j.1749-6632.1979.tb56562.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1979.tb56562.x</ArticleId><ArticleId IdType="pubmed">289325</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltonen L., Myllyl&#xe4; R., Tolonen U., Myllyl&#xe4; V.V. Changes in Collagen Metabolism in Diseased Muscle. II. Immunohistochemical Studies. Arch. Neurol. 1982;39:756&#x2013;759. doi: 10.1001/archneur.1982.00510240018005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1982.00510240018005</ArticleId><ArticleId IdType="pubmed">7138317</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xed;nguez-V&#xed;as G., Segarra A.B., Ram&#xed;rez-S&#xe1;nchez M., Prieto I. High-Fat Diets Modify the Proteolytic Activities of Dipeptidyl-Peptidase IV and the Regulatory Enzymes of the Renin&#x2013;Angiotensin System in Cardiovascular Tissues of Adult Wistar Rats. Biomedicines. 2021;9:1149. doi: 10.3390/biomedicines9091149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9091149</ArticleId><ArticleId IdType="pmc">PMC8470673</ArticleId><ArticleId IdType="pubmed">34572336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeny P.R., Brown R.G. The Aetiology of Muscular Dystrophy in Mammals&#x2014;A New Perspective and Hypothesis. Comp. Biochem. Physiol. Part B Comp. Biochem. 1981;70:27&#x2013;33. doi: 10.1016/0305-0491(81)90119-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0305-0491(81)90119-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., van Vught P.W.J., van Kempen G., Blauw H.M., Veldink J.H., van den Berg L.H. DPP6 is associated with susceptibility to progressive spinal muscular atrophy. Neurology. 2009;72:1184&#x2013;1185. doi: 10.1212/01.wnl.0000345368.01098.7e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000345368.01098.7e</ArticleId><ArticleId IdType="pubmed">19332697</ArticleId></ArticleIdList></Reference><Reference><Citation>Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., et al. Chromosome 9p21 in Amyotrophic Lateral Sclerosis in Finland: A Genome-Wide Association Study. Lancet Neurol. 2010;9:978&#x2013;985. doi: 10.1016/S1474-4422(10)70184-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70184-8</ArticleId><ArticleId IdType="pmc">PMC2965392</ArticleId><ArticleId IdType="pubmed">20801718</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson C.L., Lemmens R., Miskiewicz K., Broom W.J., Hansen V.K., van Vught P.W.J., Landers J.E., Sapp P., van den Bosch L., Knight J., et al. Variants of the Elongator Protein 3 (ELP3) Gene Are Associated with Motor Neuron Degeneration. Hum. Mol. Genet. 2009;18:472&#x2013;481. doi: 10.1093/hmg/ddn375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn375</ArticleId><ArticleId IdType="pmc">PMC2638803</ArticleId><ArticleId IdType="pubmed">18996918</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefansson H., Rujescu D., Cichon S., Pietil&#xe4;inen O.P.H., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., et al. Large Recurrent Microdeletions Associated with Schizophrenia. Nature. 2008;455:232&#x2013;236. doi: 10.1038/nature07229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07229</ArticleId><ArticleId IdType="pmc">PMC2687075</ArticleId><ArticleId IdType="pubmed">18668039</ArticleId></ArticleIdList></Reference><Reference><Citation>De Kovel C.G.F., Trucks H., Helbig I., Mefford H.C., Baker C., Leu C., Kluck C., Muhle H., von Spiczak S., Ostertag P., et al. Recurrent Microdeletions at 15q11.2 and 16p13.11 Predispose to Idiopathic Generalized Epilepsies. Brain. 2010;133:23&#x2013;32. doi: 10.1093/brain/awp262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp262</ArticleId><ArticleId IdType="pmc">PMC2801323</ArticleId><ArticleId IdType="pubmed">19843651</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauw H.M., Veldink J.H., van Es M.A., van Vught P.W., Saris C.G., van der Zwaag B., Franke L., Burbach J.P.H., Wokke J.H., Ophoff R.A., et al. Copy-Number Variation in Sporadic Amyotrophic Lateral Sclerosis: A Genome-Wide Screen. Lancet Neurol. 2008;7:319&#x2013;326. doi: 10.1016/S1474-4422(08)70048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70048-6</ArticleId><ArticleId IdType="pubmed">18313986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S., Blauw H.M., Veldink J.H., van Es M.A., Ophoff R.A., Bradley D.G., van den Berg L.H., Hardiman O. Analysis of Genome-Wide Copy Number Variation in Irish and Dutch ALS Populations. Hum. Mol. Genet. 2008;17:3392&#x2013;3398. doi: 10.1093/hmg/ddn233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn233</ArticleId><ArticleId IdType="pubmed">18689356</ArticleId></ArticleIdList></Reference><Reference><Citation>Wain L.V., Pedroso I., Landers J.E., Breen G., Shaw C.E., Leigh P.N., Brown R.H., Tobin M.D., Al-Chalabi A. The Role of Copy Number Variation in Susceptibility to Amyotrophic Lateral Sclerosis: Genome-Wide Association Study and Comparison with Published Loci. PLoS ONE. 2009;4:e8175. doi: 10.1371/journal.pone.0008175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008175</ArticleId><ArticleId IdType="pmc">PMC2780722</ArticleId><ArticleId IdType="pubmed">19997636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui K.S. Brain-Specific Aminopeptidase: From Enkephalinase to Protector against Neurodegeneration. Neurochem. Res. 2007;32:2062&#x2013;2071. doi: 10.1007/s11064-007-9356-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-007-9356-3</ArticleId><ArticleId IdType="pubmed">17476590</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas F., Wangesteen R., Rodr&#xed;guez-G&#xf3;mez I., Garc&#xed;a-Esta&#xf1; J. Aminopeptidases in Cardiovascular and Renal Function. Role as Predictive Renal Injury Biomarkers. Int. J. Mol. Sci. 2020;21:5615. doi: 10.3390/ijms21165615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165615</ArticleId><ArticleId IdType="pmc">PMC7460675</ArticleId><ArticleId IdType="pubmed">32764495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny A.J., Bourne A. Cellular Reorganisation of Membrane Peptidases in Wallerian Degeneration of Pig Peripheral Nerve. J. Neurocytol. 1991;20:875&#x2013;885. doi: 10.1007/BF01190466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01190466</ArticleId><ArticleId IdType="pubmed">1684807</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R., D&#x2019;Ovidio F., Logroscino G., Chi&#xf2; A. The Links between Diabetes Mellitus and Amyotrophic Lateral Sclerosis. Neurol. Sci. 2021;42:1377&#x2013;1387. doi: 10.1007/s10072-021-05099-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05099-0</ArticleId><ArticleId IdType="pmc">PMC7955983</ArticleId><ArticleId IdType="pubmed">33544228</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S.H., Bae Y.S., Oh S.P., Song W.S., Chang H., Kim M.H. Altered Hippocampal Gene Expression, Glial Cell Population, and Neuronal Excitability in Aminopeptidase P1 Deficiency. Sci. Rep. 2021;11:932. doi: 10.1038/s41598-020-79656-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79656-6</ArticleId><ArticleId IdType="pmc">PMC7806765</ArticleId><ArticleId IdType="pubmed">33441619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood F., Fu S., Cooke J., Wilson S.W., Cooper J.D., Russell C. A Zebrafish Model of CLN2 Disease Is Deficient in Tripeptidyl Peptidase 1 and Displays Progressive Neurodegeneration Accompanied by a Reduction in Proliferation. Brain. 2013;136:1488&#x2013;1507. doi: 10.1093/brain/awt043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt043</ArticleId><ArticleId IdType="pubmed">23587805</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz M.L., Coates J.R., Sibigtroth C.M., Taylor J.D., Carpentier M., Young W.M., Wininger F.A., Kennedy D., Vuillemenot B.R., O&#x2019;Neill C.A. Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease) J. Neurosci. Res. 2014;92:1591&#x2013;1598. doi: 10.1002/jnr.23423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23423</ArticleId><ArticleId IdType="pmc">PMC4263309</ArticleId><ArticleId IdType="pubmed">24938720</ArticleId></ArticleIdList></Reference><Reference><Citation>Quitterer U., AbdAlla S. Improvements of Symptoms of Alzheimer`s Disease by Inhibition of the Angiotensin System. Pharmacol. Res. 2020;154:104230. doi: 10.1016/j.phrs.2019.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.04.014</ArticleId><ArticleId IdType="pubmed">30991105</ArticleId></ArticleIdList></Reference><Reference><Citation>Devin J.K., Pretorius M., Nian H., Yu C., Billings F.T., IV, Brown N.J. Substance P Increases Sympathetic Activity during Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition. Hypertension. 2014;63:951&#x2013;957. doi: 10.1161/HYPERTENSIONAHA.113.02767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.113.02767</ArticleId><ArticleId IdType="pmc">PMC3984385</ArticleId><ArticleId IdType="pubmed">24516103</ArticleId></ArticleIdList></Reference><Reference><Citation>Banegas I., Prieto I., Segarra A.B., Vives F., de Gasparo M., Duran R., de Dios Luna J., Ram&#xed;rez-S&#xe1;nchez M. Bilateral Distribution of Enkephalinase Activity in the Medial Prefrontal Cortex Differs between WKY and SHR Rats Unilaterally Lesioned with 6-Hydroxydopamine. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2017;75:213&#x2013;218. doi: 10.1016/j.pnpbp.2017.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2017.02.015</ArticleId><ArticleId IdType="pubmed">28232066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambotti-Villela L., Yamasaki S.C., Villarroel J.S., Alponti R.F., Silveira P.F. Aspartyl, Arginyl and Alanyl Aminopeptidase Activities in the Hippocampus and Hypothalamus of Streptozotocin-Induced Diabetic Rats. Brain Res. 2007;1170:112&#x2013;118. doi: 10.1016/j.brainres.2007.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.07.026</ArticleId><ArticleId IdType="pubmed">17692297</ArticleId></ArticleIdList></Reference><Reference><Citation>Stragier B., Demaegdt H., De Bundel D., Smolders I., Sarre S., Vauquelin G., Ebinger G., Michotte Y., Vanderheyden P. Involvement of Insulin-Regulated Aminopeptidase and/or Aminopeptidase N in the Angiotensin IV-Induced Effect on Dopamine Release in the Striatum of the Rat. Brain Res. 2007;1131:97&#x2013;105. doi: 10.1016/j.brainres.2006.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.11.010</ArticleId><ArticleId IdType="pubmed">17169335</ArticleId></ArticleIdList></Reference><Reference><Citation>Banegas I., Barrero F., Dur&#xe9;n R., Morales B., Luna J.D., Prieto I., Ram&#xed;rez M., Alba F., Vives F. Plasma Aminopeptidase Activities in Parkinson&#x2019;s Disease. Horm. Metab. Res. 2006;38:758&#x2013;760. doi: 10.1055/s-2006-955088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2006-955088</ArticleId><ArticleId IdType="pubmed">17111304</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes M.T., Murari-do-Nascimento S., Torrigo I.R., Alponti R.F., Yamasaki S.C., Silveira P.F. Basic Aminopeptidase Activity Is an Emerging Biomarker in Collagen-Induced Rheumatoid Arthritis. Regul. Pept. 2011;167:215&#x2013;221. doi: 10.1016/j.regpep.2011.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.regpep.2011.02.012</ArticleId><ArticleId IdType="pubmed">21324345</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhold D., Bank U., Entz D., Goihl A., Stoye D., Wrenger S., Brocke S., Thielitz A., Stefin S., Nordhoff K., et al. PETIR-001, a Dual Inhibitor of Dipeptidyl Peptidase IV (DP IV) and Aminopeptidase N (APN), Ameliorates Experimental Autoimmune Encephalomyelitis in SJL/J Mice. Biol. Chem. 2011;392:233&#x2013;237. doi: 10.1515/bc.2011.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bc.2011.024</ArticleId><ArticleId IdType="pubmed">21194377</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhold D., Bank U., T&#xe4;ger M., Ansorge S., Wrenger S., Thielitz A., Lendeckel U., Faust J., Neubert K., Brocke S. DP IV/CD26, APN/CD13 and Related Enzymes as Regulators of T Cell Immunity: Implications for Experimental Encephalomyelitis and Multiple Sclerosis. Front. Biosci. 2008;13:2356&#x2013;2363. doi: 10.2741/2849.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2849</ArticleId><ArticleId IdType="pubmed">17981717</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiter A., Gore C., Labuz D., Fournie-Zaluski M.C., Roques B.P., Stein C., Machelska H. Pain Inhibition by Blocking Leukocytic and Neuronal Opioid Peptidases in Peripheral Inflamed Tissue. FASEB J. 2012;26:5161&#x2013;5171. doi: 10.1096/fj.12-208678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-208678</ArticleId><ArticleId IdType="pubmed">22923332</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Liu X., Wei Y., Li X., Gao S., Dong L., Rao X., Zhong J. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease. Front. Immunol. 2022;13:830863. doi: 10.3389/fimmu.2022.830863.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.830863</ArticleId><ArticleId IdType="pmc">PMC8931313</ArticleId><ArticleId IdType="pubmed">35309368</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo F.J., Pinto-Lopes P., Estevinho M.M., Magro F. The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review. Inflamm. Bowel Dis. 2021;27:1153&#x2013;1165. doi: 10.1093/ibd/izaa324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa324</ArticleId><ArticleId IdType="pubmed">33295607</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumaravel S., Luo G.R., Huang S.T., Lin H.Y., Lin C.M., Lee Y.C. Development of a Novel Latent Electrochemical Molecular Substrate for the Real-Time Monitoring of the Tumor Marker Aminopeptidase N in Live Cells, Whole Blood and Urine. Biosens. Bioelectron. 2022;203:114049. doi: 10.1016/j.bios.2022.114049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2022.114049</ArticleId><ArticleId IdType="pubmed">35134686</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa T., Mizutani S., Matsumoto K., Kato Y., Yoshihara M., Kajiyama H., Shibata K. Placental Leucine Aminopeptidase as a Potential Specific Urine Biomarker for Invasive Ovarian Cancer. J. Clin. Med. 2021;11:222. doi: 10.3390/jcm11010222.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11010222</ArticleId><ArticleId IdType="pmc">PMC8746293</ArticleId><ArticleId IdType="pubmed">35011963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang L., Zhang N., Xia Y., Wang D., Wang G., Meng X. Serum APN/CD13 as a Novel Diagnostic and Prognostic Biomarker of Pancreatic Cancer. Oncotarget. 2016;7:77854&#x2013;77864. doi: 10.18632/oncotarget.12835.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.12835</ArticleId><ArticleId IdType="pmc">PMC5363626</ArticleId><ArticleId IdType="pubmed">27788483</ArticleId></ArticleIdList></Reference><Reference><Citation>Abouzied M.M., Eltahir H.M., Fawzy M.A., Abdel-Hamid N.M., Gerges A.S., El-Ibiari H.M., Nazmy M.H. Estimation of Leucine Aminopeptidase and 5-Nucleotidase Increases Alpha-Fetoprotein Sensitivity in Human Hepatocellular Carcinoma Cases. Asian Pac. J. Cancer Prev. 2015;16:959&#x2013;963. doi: 10.7314/APJCP.2015.16.3.959.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2015.16.3.959</ArticleId><ArticleId IdType="pubmed">25735389</ArticleId></ArticleIdList></Reference><Reference><Citation>Megias M.J., Alba-Araguez F., Luna J.D., Vives F., Ramirez-Sanchez M. Serum Pyroglutamyl Aminopeptidase Activity: A Promising Novel Biomarker Candidate for Liver Cirrhosis. Endocr. Regul. 2015;49:20&#x2013;24. doi: 10.4149/endo_2015_01_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/endo_2015_01_20</ArticleId><ArticleId IdType="pubmed">25687677</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner L., Wolf R., Zeitschel U., Rossner S., Peters&#xe9;n &#xc5;., Leavitt B.R., K&#xe4;stner F., Rothermundt M., G&#xe4;rtner U.T., G&#xfc;ndel D., et al. Proteolytic Degradation of Neuropeptide Y (NPY) from Head to Toe: Identification of Novel NPY-Cleaving Peptidases and Potential Drug Interactions in CNS and Periphery. J. Neurochem. 2015;135:1019&#x2013;1037. doi: 10.1111/jnc.13378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13378</ArticleId><ArticleId IdType="pubmed">26442809</ArticleId></ArticleIdList></Reference><Reference><Citation>Quesada A., Segarra A.B., Montoro-Molina S., De Gracia M.D.C., Osuna A., O&#x2019;Valle F., G&#xf3;mez-Guzm&#xe1;n M., Vargas F., Wangensteen R. Glutamyl Aminopeptidase in Microvesicular and Exosomal Fractions of Urine Is Related with Renal Dysfunction in Cisplatin-Treated Rats. PLoS ONE. 2017;12:e0175462. doi: 10.1371/journal.pone.0175462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0175462</ArticleId><ArticleId IdType="pmc">PMC5388492</ArticleId><ArticleId IdType="pubmed">28399178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>